BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rutgers Addiction Research Center (RARC) - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rutgers Addiction Research Center (RARC)
X-ORIGINAL-URL:https://www.addiction.rutgers.edu
X-WR-CALDESC:Events for Rutgers Addiction Research Center (RARC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240607T090000
DTEND;TZID=America/New_York:20240607T120000
DTSTAMP:20260417T212238
CREATED:20240320T153941Z
LAST-MODIFIED:20240320T153941Z
UID:6805-1717750800-1717761600@www.addiction.rutgers.edu
SUMMARY:GSAPP Webinar - Opioid Addiction and Its Treatment: What Every Psychotherapist Needs to Know
DESCRIPTION:Description \nAn unremitting epidemic of opioid use and overdose deaths highlights the need for all mental health therapists\, regardless of professional discipline or specialty area\, to know how to evaluate\, diagnose\, engage\, treat\, and/or refer opioid-using clients they are likely to encounter in office-based practice and other clinical settings. Although medication is often the first-line treatment for opioid dependence\, the combination of targeted pharmacotherapy and psychotherapy is often more effective than either one alone. This presentation will describe the scope and consequences of opioid use; the clinical pharmacology of opioid drugs\, clinical assessment and diagnosis\, individualized treatment planning\, medications for treating opioid use disorders (including buprenorphine and naltrexone)\, and a client-centered psychotherapeutic approach that integrates evidence-based behavioral and pharmacological interventions within a harm reduction framework. Lecture material will be interspersed with case vignettes to illustrate the clinical application of this approach. \nLearning Objectives \nAs a result of attending this presentation\, participants will be able to: \n\nSummarize the scope and public health consequences of opioid use in the U.S.\nExplain the unique pharmacological actions of opioids in the body and brain.\nDescribe the most effective medications for treating opioid dependence and specific indications for their use.\nSummarize the components of an individualized client-centered approach that integrates pharmacological and behavioral interventions.\n\nInstructor Bio \nDr. Washton is a psychologist\, book author\, and founder of The Washton Group\, a private practice specializing on the treatment of substance use disorders in executives\, professionals\, adolescents\, and young adults. He has served as Clinical Professor of Psychiatry at NYU School of Medicine\, director of several nationally recognized addiction treatment programs\, principal investigator of research grants from the National Institute on Drug Abuse\, and consultant to professional sports teams\, government agencies\, media organizations\, and major corporations. He has also served as substance abuse advisor to the U.S. Food and Drug Administration\, special committees of The U.S. Senate and House of Representatives\, and the American Psychological Association. Dr. Washton has authored over 100 journal articles and nine books including “Treating Alcohol and Drug Problems in Psychotherapy Practice: Doing What Works” (2nd Edition\, 2022). \nFor more information and registration\, click here.
URL:https://www.addiction.rutgers.edu/event/gsapp-webinar-opioid-addiction-and-its-treatment-what-every-psychotherapist-needs-to-know-2/
LOCATION:Virtual
ORGANIZER;CN="Rutgers Graduate School of Applied and Professional Psychology":MAILTO:ce@gsapp.rutgers.edu
END:VEVENT
END:VCALENDAR